Respiratory Support in Acute Respiratory Distress

Introduction to HFNC and BiPAP

The European Respiratory Society suggests HFNC over BiPAP for hypoxemic respiratory failure, while BiPAP is preferred for hypercapnic respiratory failure 1, 2

HFNC delivers high flow rates of heated and humidified oxygen-air mixture, creating a washout effect in the upper airways, reducing anatomical dead space, and provides modest positive end-expiratory pressure (PEEP) effect of approximately 2-5 cmH2O at 50-60 L/min 4
BiPAP delivers two different pressure levels: higher inspiratory positive airway pressure (IPAP) and lower expiratory positive airway pressure (EPAP), providing pressure support to augment tidal volume, and can deliver higher and more controlled PEEP levels, typically 4-12 cmH2O 4

The European Respiratory Society recommends using HFNC for acute hypoxemic respiratory failure (primary indication) 1, 2
The European Respiratory Society suggests using HFNC for patients with moderate to severe acute hypoxemic respiratory failure (PaO2/FiO2 ≤200 mmHg) 2, 5
HFNC is recommended for post-operative patients at low risk of respiratory complications 6
BiPAP is indicated for hypercapnic respiratory failure (primary indication), such as COPD exacerbations 3, 4
BiPAP is recommended for patients with neuromuscular diseases or ICU-associated muscle weakness 3

HFNC may reduce mortality compared to BiPAP in acute hypoxemic respiratory failure (risk ratio 0.77, 95% CI 0.52 to 1.14) 1, 2
BiPAP typically achieves higher PaO2/FiO2 ratios compared to HFNC 3, 4
HFNC is generally better tolerated with higher comfort levels due to the heated and humidified oxygen delivery system and less restrictive interface 4

For HFNC, monitor response within 1-2 hours of initiation 3
For BiPAP, improvement in gas exchange within 1 hour (PaO2/FiO2 <175 mmHg after 1 hour of NIV is associated with need for intubation) 2
Monitor expired tidal volume in BiPAP patients (exceeding 9-9.5 mL/kg predicted body weight while on BiPAP can predict treatment failure) 2

Delaying intubation when either HFNC or BiPAP is failing can lead to worse outcomes; close monitoring is essential 4
NIV failure occurs more frequently in patients with more severe ARF: PaO2/FiO2 <200 mmHg before treatment and higher Simplified Acute Physiology Score II (>35) are associated with a two-fold risk of intubation 2
Resource considerations may influence device selection, as BiPAP may require more intensive monitoring in some settings 4
In low-income countries, HFNC may reduce health equity due to high oxygen consumption 5